Victor S. Wasehuus - Publications

Left ventricular ejection fraction reserve and its association with myocardial perfusion, coronary calcification, and strain in type 2 diabetes without overt cardiovascular disease.

Journal: Cardiovascular diabetology

Published: June 11, 2025

Effects of combined treatment with zibotentan and dapagliflozin compared to dapagliflozin alone in patients with diabetic and non-diabetic chronic kidney disease.

Journal: Diabetes, obesity & metabolism

Published: February 18, 2025

Sex differences in myocardial flow reserve among individuals with type 2 diabetes: insights from the DiaHeart study.

Journal: Cardiovascular diabetology

Published: February 10, 2025

Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study.

Journal: Diabetes, obesity & metabolism

Published: July 23, 2024

Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: July 01, 2024

Effects of Zibotentan Alone and in Combination with Dapagliflozin on Fluid Retention in Patients with CKD.

Journal: Journal of the American Society of Nephrology : JASN

Published: March 25, 2024

Late diagnosis of partial 3β-hydroxysteroid dehydrogenase type 2 deficiency - characterization of a new genetic variant.

Journal: Endocrinology, diabetes & metabolism case reports

Published: August 09, 2023

Increased Subclinical Coronary Artery Pathology in Type 2 Diabetes With Albuminuria.

Journal: Diabetes

Published: July 07, 2023

Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: A randomized and placebo-controlled study.

Journal: Diabetes, obesity & metabolism

Published: July 05, 2023